Sonoma Biotherapeutics
An experienced Regulatory Affairs professional leads global regulatory strategies for late-phase clinical development of gene therapy products in autoimmune and degenerative diseases. The role involves managing complex submissions like INDs and BLAs, interfacing with regulatory agencies, and collaborating with cross-functional R&D teams. Based primarily at the South San Francisco headquarters, the position requires hands-on leadership to drive adherence to FDA, EMA, and ICH guidelines.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2019
Developing living cell therapies designed to restore balance to the immune system and ultimately cure autoimmune and inflammatory disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sonoma Biotherapeutics.
Sonoma Biotherapeutics didn’t post a salary, so this is our estimate from similar listings.
24% above the average for this role